Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Special Report: Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives RECCE® 327 ...

Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Basilea Pharmaceutica announces commercial availability of antibiotic Zevtera in United States: Allschwil, Switzerland Wednesday, May 21, 2025, 11:00 Hrs [IST] Basilea Pharmaceuti ...

The antibiotic, cefoxitin, with the best coverage against Gram-negative anaerobes, is administered in a single dose. Antibiotic regimens prospectively studied with little to no activity against ...

Learn about the battle against antimicrobial resistance (AMR) in India, the development of new antibiotics, and the urgent ...

Lazard acted as the exclusive financial advisor to Paratek Pharmaceuticals, and Skadden, Arps, Slate, Meagher & Flom LLP served as its legal advisor. Evercore acted as the exclusive financial advisor ...